JP2017505911A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505911A5
JP2017505911A5 JP2016550860A JP2016550860A JP2017505911A5 JP 2017505911 A5 JP2017505911 A5 JP 2017505911A5 JP 2016550860 A JP2016550860 A JP 2016550860A JP 2016550860 A JP2016550860 A JP 2016550860A JP 2017505911 A5 JP2017505911 A5 JP 2017505911A5
Authority
JP
Japan
Prior art keywords
cells
antibody
sample
binding
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016550860A
Other languages
English (en)
Japanese (ja)
Other versions
JP6685229B2 (ja
JP2017505911A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2015/050060 external-priority patent/WO2015120523A1/en
Publication of JP2017505911A publication Critical patent/JP2017505911A/ja
Publication of JP2017505911A5 publication Critical patent/JP2017505911A5/ja
Application granted granted Critical
Publication of JP6685229B2 publication Critical patent/JP6685229B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016550860A 2014-02-17 2015-02-17 癌を検出する方法 Active JP6685229B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014900494 2014-02-17
AU2014900494A AU2014900494A0 (en) 2014-02-17 Methods of detecting cancer
PCT/AU2015/050060 WO2015120523A1 (en) 2014-02-17 2015-02-17 Method of detecting cancer

Publications (3)

Publication Number Publication Date
JP2017505911A JP2017505911A (ja) 2017-02-23
JP2017505911A5 true JP2017505911A5 (https=) 2018-03-29
JP6685229B2 JP6685229B2 (ja) 2020-04-22

Family

ID=53799455

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016550860A Active JP6685229B2 (ja) 2014-02-17 2015-02-17 癌を検出する方法

Country Status (9)

Country Link
US (2) US10338072B2 (https=)
EP (1) EP3108256B1 (https=)
JP (1) JP6685229B2 (https=)
CN (1) CN106461666B (https=)
AU (1) AU2015218188B2 (https=)
DK (1) DK3108256T3 (https=)
ES (1) ES2818089T3 (https=)
IL (1) IL247270B (https=)
WO (1) WO2015120523A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3108256T3 (da) 2014-02-17 2020-09-21 Sienna Cancer Diagnostics Ltd Fremgangsmåde til detektering af cancer
US20180238891A1 (en) * 2015-08-19 2018-08-23 Sienna Cancer Diagnostics Ltd Cancer Detection Method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09262100A (ja) * 1996-03-27 1997-10-07 Mount Sinai School Medicine City Univ New York テロメラーゼ活性の存在を測定することによる尿試料中のヒト膀胱癌細胞の検出方法
NZ528205A (en) * 2001-03-12 2006-09-29 Monogen Inc Cell-based detection and differentiation of disease status in a cytological sample using a panel comprising a plurality of probes
ES2360954T3 (es) 2005-02-18 2011-06-10 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Procedimientos para detectar la evolución de la displasia de cuello uterino de bajo grado.
US20090142259A1 (en) * 2006-05-12 2009-06-04 Genentech, Inc. Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
WO2009075803A2 (en) 2007-12-05 2009-06-18 The Johns Hopkins University Alternative splice variant patterns of human telomerase reverse transcriptase (htert) in thyroid tumors to distinguish benign from malignant
DK3108256T3 (da) 2014-02-17 2020-09-21 Sienna Cancer Diagnostics Ltd Fremgangsmåde til detektering af cancer
US20180238891A1 (en) 2015-08-19 2018-08-23 Sienna Cancer Diagnostics Ltd Cancer Detection Method

Similar Documents

Publication Publication Date Title
Zahel et al. Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach
Shao et al. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer
JP2017518366A5 (https=)
Pathmanathan et al. Ki67 and proliferation in breast cancer
Wendel et al. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology
Slater et al. LCN2 and TIMP1 as potential serum markers for the early detection of familial pancreatic cancer
Liu et al. The RML of lymph node metastasis was superior to the LODDS for evaluating the prognosis of gastric cancer
JP2014524744A5 (https=)
Yim et al. Novel predictors for lymph node metastasis in submucosal invasive colorectal carcinoma
JP2018535404A5 (https=)
RU2017119009A (ru) Анализы для обнаружения субпопуляций иммунных т-клеток и способы их применения
JP2012073260A5 (https=)
JP5370826B2 (ja) 癌の組織型を判別するカクテル抗体、判別キット及び判別方法
Zhu et al. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma
JP2017532577A5 (https=)
Conner et al. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies
Sheng et al. Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells
Jiang et al. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors
Asch-Kendrick et al. NKX3. 1 is expressed in ER-positive and AR-positive primary breast carcinomas
Troppan et al. The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma
Su et al. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas
JP2015507175A5 (https=)
Hugen et al. Circulating tumor cells in genitourinary malignancies: an evolving path to precision medicine
Liu et al. A machine learning approach yields a multiparameter prognostic marker in liver cancer
JP2017505911A5 (https=)